Raphael Pharmaceutical (RAPH) Interest Coverage Ratio (2020 - 2024)

Raphael Pharmaceutical (RAPH) has 5 years of Interest Coverage Ratio data on file, last reported at 0.26 in Q4 2024.

• For the quarter ending Q4 2024, Interest Coverage Ratio fell 342.79% year-over-year to 0.26; the trailing twelve-month figure through Dec 2024 stood at 0.98 (up 2.04% YoY), and the FY2025 full-year result was 0.63, up 36.14% from the prior year.
• Interest Coverage Ratio eased to 0.26 in Q4 2024, from 0.11 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 0.11 in Q4 2023 to a low of 1.52 in Q4 2022.
• A 5-year average of 0.71 and a median of 0.46 in 2021 frame the typical range for Interest Coverage Ratio.
• Across the five-year window, Interest Coverage Ratio surged 106.95% in 2023 and plunged 342.79% in 2024, its largest moves.
• Tracing RAPH's Interest Coverage Ratio over 5 years: stood at 1.44 in 2020, then jumped by 67.86% to 0.46 in 2021, then sank by 228.85% to 1.52 in 2022, then soared by 106.95% to 0.11 in 2023, then plunged by 342.79% to 0.26 in 2024.
• Business Quant data shows RAPH's Interest Coverage Ratio at 0.26 in Q4 2024, 0.11 in Q4 2023, and 1.52 in Q4 2022.